DRNZ

DRNZ remains in a Stage 4 decline with a medium-term bearish bias confirmed by price below all major EMAs. The recent relief bounce has not reclaimed the declining 9-day and 20-day EMAs, offering no clear rejection signal. It is prudent to defer selling until a decisive rejection at those EMAs or nearby resistance rather than forcing an immediate sale.

• ↑Pentagon invested $1.3 B in drone initiatives, boosting sector demand.
• ↑NextVision reported Q1 revenue of $67.4 M, +86% YoY; 2026 target ~$315 M.
• ↓DRNZ performance is in the bottom 20% of US-listed ETFs YTD.